Filter
1081
Filtered Results: 1081
Text search:
rifampicina
Featured
Recommendations
124
New Publications
292
Language
Document type
No document type
717
Guidelines
154
Studies & Reports
86
Manuals
50
Strategic & Response Plan
27
Training Material
19
Fact sheets
17
Situation Updates
6
Infographics
3
App
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
58
India
58
Eastern Europe
32
South Africa
25
Nepal
23
Latin America and the Carribbean
22
Kenya
20
Tanzania
18
Colombia
16
Argentina
16
Peru
15
Nigeria
14
Germany
14
Bangladesh
14
Namibia
14
Paraguay
13
Uganda
13
Indonesia
13
Global
12
Brazil
12
Ethiopia
12
Zambia
12
El Salvador
11
Rwanda
11
Malawi
10
Bolivia
10
Philippines
9
Cambodia
9
South–East Asia Region
9
Myanmar / Burma
9
Ukraine
8
Senegal
7
Mozambique
7
Africa
7
Asia
7
Cameroon
6
Congo, Democratic Republic of
6
Russia
6
Tajikistan
5
Uruguay
5
Ecuador
5
Eswatini/ Swaziland
5
Ghana
4
Benin
4
Chile
4
Venezuela
4
Botswana
4
Lesotho
3
Sierra Leone
3
Burkina Faso
3
Zimbabwe
3
Georgia
3
Bhutan
3
Madagascar
3
Pakistan
3
Timor Leste/ East Timor
2
Syria
2
Armenia
2
Haiti
2
Eastern Europe and Central Asia
2
Sri Lanka
2
Liberia
2
North Macedonia
1
North Korea
1
Switzerland
1
Thailand
1
Mexico
1
Serbia
1
Gambia
1
Togo
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Morocco
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
North America
1
Turkmenistan
1
Tunisia
1
Spain
1
Lebanon
1
Vietnam
1
Nicaragua
1
Sudan
1
Yemen
1
Romania
1
Greece
1
Honduras
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
259
TB
85
Guidelines
67
Studies & Reports
51
Drugs & Medical Equipment
43
Capacity Building
29
Policies
26
Women & Child Health
21
HIV & STI
21
Pediatrics
18
Statistics
18
Disease Prevention & Control
12
Community Health
10
Paediatrics
9
Bacteriology
9
Buruli Ulcer
8
COVID-19
8
Leprosy
8
Reproductive Health
8
Leprosy
7
Family Planning
6
Dermatology
6
Maternal & Child Health
5
Countries
5
Clinical Guidelines
5
Demograhic Health Surveys DHS
5
Communicable Diseases
5
NTDs & Others
5
Community Health
4
Vaccine-preventable Diseases
4
Communicable Diseases
3
Infection Control & Prevention (IPC)
3
Public Health
3
Health Systems
3
Clinical Training
2
Hepatitis
2
Under-5 nutrition
2
Diabetes
2
Trachoma
2
Lymphaticfilariasis
2
Humanitarian Aid
2
Monitoring & Evaluation
2
Virology
2
Medical Devices & Equipment
2
Humanitarian Crisis
2
Other
2
General Guidelines
2
Leishmaniasis
2
Dental & Eye Care
1
Public Health
1
Pharmacy & Technology
1
Child Health
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
x MEDBOX Issue Brief & Annual Reports x
1
General Guidelines
1
IEC Material
1
Health System Strengthening
1
Information, Education and Communication (IEC)
1
Disabilities
1
Respiratory Infections
1
Needs Assessment
1
Primary Health Care
1
Malaria
1
Pharmacy & Technologies
1
Toolboxes
Prevention & Control
54
Drug resistant TB
51
Detection & Diagnosis
50
Adults
43
Children
27
Training
25
TB/HIV Coinfection
24
Essential Medicines & Devices Lists
21
Childhood TB
17
TB & Prisoners
17
Reports
16
Antiretroviral Treatment ART
16
Research & Access
15
General
14
TB
14
Policies & Strategies
13
Treatment & Prevention
13
Children & Adolescents
13
Laboratory
13
Disease Prevention & Control
13
Clinical Aspects, Treatment & Prevention
12
Clinical Aspects
12
Colombia
12
Peru
12
AmR (Region of Americas)
12
Brazil
11
Other Countries
11
Clinical Aspects & Diagnostics
11
Romania
11
Germany
11
Eastern Europe & Central Asia
11
SEAR (South-east Asia Region)
10
Moldova
9
Policies & Strategies
9
Treatment Guidelines HIV
9
El Salvador
9
Argentina
9
Studies & Reports
9
Reports & Studies
9
Country specific
8
Prevention & Control
8
TB & Other Vulnerable Populations
8
TB/HIV
8
Country Guidelines
7
International
7
Communication & Training
7
Advocacy & Communication
7
HIV &TB
7
Policies and guidelines
7
HIV and coinfection
7
Treatment & Clinical Management
7
Biosafety
6
South Africa
6
Namibia
6
Drug resistance
6
Studies
6
Overview
6
Essential Medicines
6
General
6
TB/HIV Global
6
Uganda
6
South-east Asia Region
6
Epidemiology
6
Kenya
6
ART Drug Resistance
5
TB & Drug Abuse
5
Ukraine
5
Rwanda
5
TB/COVID-19
5
Diagnosis
5
Malawi
5
Assessment
5
Clinical Guidelines
5
Opportunistic Infections
4
Training Manuals
4
Ethiopia
4
Clinical Guidelines
4
Community Health Workers CHW
4
Chile
4
Ecuador
4
Falsified & Substandard
4
Tuberculosis
4
Nutrition
4
Latin America & the Carribean
4
Tajikistan
4
Kazakhstan
4
Western & Central Europe
4
Eastern Europe and central Asia
4
General Reports
3
Azerbaijan
3
Vaccines & Immunization
3
Epidemiology & Sitreps
3
Eastern Mediterranean Region
3
National Policies
3
IEC Materials
3
Mozambique
3
Georgia
3
Clinical aspects
3
Workplace
3
Clinical Guidelines
3
Country specific documents
3
Hospital Readiness/Essential Health Services
3
Latin America
3
Pharmacy Practice
3
Rational use of Medicine
3
Access to treatment and laboratory
3
Co-Morbidities (except TB)
3
Prophylactic Treatment
3
Nigeria
3
Drugs
2
Behaviour Change/Life Skill Education
2
Meningitis Prevention & Control
2
Clinical Guidelines
2
Pediatrics
2
WPRO (Western Pacific Region)
2
HIV
2
TB
2
Prophylaxis
2
SOPs
2
Health & Refugee
2
Epilepsy
2
Sustainable Development Goals
2
General
2
Essential List
2
Country Specific
2
Global Impact: Socio-economic, health services, TB & HIV
2
Others
2
Latin America
2
Prices and Patents
2
Model Formulary
2
Prevention & Measures
2
Disability Prevention & Rehabilitation
2
Information & Education Material (IEC)
2
NTDs General
2
Capacity Building & Resource platforms
2
Health Worker
2
Neurological Disorders
2
Ghana
2
HIV service delivery
2
Meningitis & Encephalitis
2
Clinical Guidelines
1
Surveillance
1
Agriculture & Veterinary
1
HIV testing & services
1
Clinical Guidelines
1
Zambia
1
Prevention Guidelines
1
Policies
1
Public Health
1
Eastern Europe
1
Global
1
People who injecting Drugs
1
Vaccination
1
African Region
1
Laboratory
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
Russia
1
DR Congo
1
Laboratory
1
Research & Development
1
Estonia
1
Pharmaceutical Assessments
1
General documents One Health
1
Guidelines & Manuals
1
General
1
Health Care In Conflict Settings
1
Leishmaniasis
1
Strategies & Roadmaps
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Clinical Aspects & Diagnostics
1
Vector control
1
Armenia
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Asia and Pacific
1
Botswana
1
General
1
Substance Use Disorders & Addiction
1
Community Worker
1
General Aspects
1
AR (African Region)
1
Education of students & professionals
1
Lesotho
1
HIV / AIDS
1
Testing Guidelines
1
Stigma
1
Overview & Statistics
1
MHPSS Guidelines
1
Guidelines CBR
1
Reports & Studies Children HIV
1
Lobby and Advocacy
1
HIV in Key Populations
1
Preparedness & Prevention
1
Global Health Financing
1
Unaccompanied Refugee Minors
1
Case Definitions
1
Prisoners
1
Key Resources
1
AMR
1
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifa...
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
La publicación describe el funcionamiento del método rápido, confiable, sencillo y económico al laboratorio que permita examinar un gran número de muestras a fin de seleccionar a aquellos pacientes que pudieran estar potencialmente infectados con Mycobacterium tuberculosis multirresistente a lo...
Автоматизированная технология амплификации нуклеиновых кислот в режиме реального времени для быстрого и одновременного выявления туберкулеза и устойчивости к р...
Phillips and colleagues have shown that rifampicin combined with clarithromycin is non-inferior to RS8, and is safer. This much anticipated trial provides us with a high degree of confidence that an 8-week course of oral rifampicin and clarithromycin should now be the cornerstone of the treatment of...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and analyzed in the laboratory of Instituto Nacional de In...
La publicación describe el método aplicado en los laboratorios que han realizado la validación, como un método rápido de tamizaje para la detección de resistencia a isoniacida y rifampicina en muestras de esputo de pacientes con tuberculosis pulmonar que aún no hayan iniciado tratamiento anti...
Of the more than 10 million people estimated to have fallen ill with tuberculosis (TB) in 2022, just over 400 000 people developed TB resistant to rifampicin (RIF), and 1.3 million people developed TB resistant isoniazid (INH). Drug resistance must be detected rapidly and accurately to initiate appr...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
